| |
| |
|
| Insider
Information: |
Meisner Derek M |
| Relationship: |
Chief Legal Officer & ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
254,022 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$158,219 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
254,022 |
|
|
| Total
Value |
$158,219 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genocea Biosciences, Inc. |
GNCA |
|
|
0 |
|
0 |
Premium* |
|
|
X4 Pharmaceuticals Inc |
XFOR |
Chief Legal Officer |
2022-08-17 |
145,155 |
2020-08-14 |
0 |
Premium* |
|
|
Acumen Pharmaceuticals, Inc. |
ABOS |
Chief Legal Officer & ... |
2024-01-19 |
108,867 |
2023-01-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABOS |
Acumen Pharmaceuticals, I... |
Chief Legal Officer & Corp Sec |
• – – |
2024-01-19 |
4 |
AS |
$3.48 |
$31,048 |
D/D |
(8,933) |
108,867 |
0 |
- |
|
| ABOS |
Acumen Pharmaceuticals, I... |
Chief Legal Officer & Corp Sec |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
91,000 |
117,800 |
0 |
- |
|
| ABOS |
Acumen Pharmaceuticals, I... |
Chief Legal Office & Corp Sec |
• – – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,800 |
26,800 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2022-08-17 |
4 |
AS |
$0.00 |
$0 |
D/D |
(8,334) |
145,155 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2022-06-24 |
4 |
AS |
$0.00 |
$0 |
D/D |
(4,166) |
153,489 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2022-06-16 |
4 |
AS |
$0.00 |
$0 |
D/D |
(4,166) |
157,655 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
161,821 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2022-02-11 |
4 |
AS |
$0.00 |
$0 |
D/D |
(15,909) |
56,821 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-08-17 |
4 |
AS |
$5.10 |
$42,493 |
D/D |
(8,332) |
72,730 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-06-24 |
4 |
AS |
$7.00 |
$29,162 |
D/D |
(4,166) |
81,062 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
85,228 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-06-15 |
4 |
AS |
$7.84 |
$32,661 |
D/D |
(4,166) |
72,728 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
76,894 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
47,728 |
64,394 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2020-09-09 |
4 |
AS |
$8.05 |
$67,089 |
D/D |
(8,334) |
16,666 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2020-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
25,000 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
General Counsel |
• – – |
2020-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
